#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	238	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1027	12.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	226	228	ACG	13;13;13	A;C;G	13;13;13	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	184	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	110	18.8	0	.	n	.	0	G906T	SNP	906	906	G	16	16	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	184	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	110	18.8	0	.	n	.	0	G908A	SNP	908	908	G	18	18	A	10	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	184	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	110	18.8	0	.	n	.	0	A918T	SNP	918	918	A	28	28	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	184	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	110	18.8	0	.	n	.	0	A943G	SNP	943	943	A	53	53	G	36	G	36	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	184	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	110	18.8	0	.	n	.	0	G991T	SNP	991	991	G	101	101	T	21	T	21	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1008	Escherichia_coli_EF_Tu	1230	1230	99.19	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1578	33.6	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1407	1409	AGC	19;19;19	A,G;G;C	12,7;19;19	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1008	Escherichia_coli_EF_Tu	1230	1230	99.19	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1578	33.6	1	SNP	p	R234F	1	.	.	700	702	TTC	882	884	TTC	51;51;50	T;T;C	51;51;50	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1008	Escherichia_coli_EF_Tu	1230	1230	99.19	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1578	33.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1182	1184	CGT	34;36;36	C;G;T	34;36;36	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1008	Escherichia_coli_EF_Tu	1230	1230	99.19	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1578	33.6	0	HET	.	.	.	T999C	.	999	999	T	1181	1181	T	31	T,C	18,13	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1008	Escherichia_coli_EF_Tu	1230	1230	99.19	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1578	33.6	0	HET	.	.	.	C261T	.	261	261	C	443	443	C	39	C,T	25,14	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	330	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1712	10.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1524	1526	AAA	6;6;6	A;A;A	6;6;6	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	502	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1654	16.1	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1195	1197	GAA	8;8;8	G;A;A	8;8;8	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	94	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	560	8.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	400	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1414	15.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	172	174	CGT	9;10;10	C;G;T	9;10;10	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	400	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1414	15.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1015	1017	GGC	16;14;14	G;G;C	16;14;13	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	556	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1936	15.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	175	177	AGC	7;6;6	A;G;C	7;6;6	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	556	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1936	15.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	577	579	CTA	17;17;18	C;T;A	17;17;18	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	556	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1936	15.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1096	1098	CAA	19;19;19	C;A;A	19;19;19	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	556	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1936	15.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1195	1197	GGT	21;21;21	G;G;T	21;21;21	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	556	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1936	15.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1765	1767	GTT	9;9;8	G;T;T	9;9;8	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	204	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1453	7.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	596	598	GAA	4;3;3	G;A;A	4;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	204	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1453	7.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	776	778	ACC	4;4;4	A;C;C	4;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	204	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1453	7.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	896	898	ACT	3;3;3	A;C;T	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	204	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1453	7.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1286	1288	ATC	7;7;7	A;T;C	6;5;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	248	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1271	10.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	816	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3303	13.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	361	363	ATC	8;8;9	A,AC;T;C	7,1;7;8	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	816	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3303	13.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2074	2076	AAG	7;7;7	A;A;G	7;7;7	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	531	414	acrE	1158	1093	98.81	acrE.l15.c30.ctg.1	1168	17.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	741	743	TGC	13;13;14	T;G;C	13;13;14	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	161	161	T	7	T	7	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	467	469	GAC	17;16;17	G,A;A;C	16,1;16;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	743	745	TTA	3;3;3	T;T;A	3;3;3	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1820	1822	AAT	22;22;22	A;A;T	22;22;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1934	1936	AGT	17;16;19	A;G;T	17;16;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2333	2335	GTG	22;22;20	G;T;G	22;21;20	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	948	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3274	15.4	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2888	2890	AAG	10;10;10	A;A;G	9;10;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	236	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	925	13.3	1	SNP	p	R45C	0	.	.	133	135	CGC	313	315	CGC	20;21;21	C;G;C	20;21;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	200	acrS	663	663	98.79	acrS.l15.c4.ctg.1	997	10.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	246	248	TTC	11;11;11	T;T;C	11;11;11	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	200	acrS	663	663	98.79	acrS.l15.c4.ctg.1	997	10.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	510	512	GGG	8;8;8	G;G;G	8;8;8	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	262	adiY	762	762	99.61	adiY.l15.c30.ctg.1	946	13.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	478	480	CTT	18;18;18	C;T;T	18;18;18	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	870	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	2979	15.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2037	2039	GCA	19;20;21	G;C;A	19;20;21	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	870	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	2979	15.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2298	2300	ACC	14;15;15	A,C;C;C	11,1;15;15	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	870	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	2979	15.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2607	2609	GCC	18;18;17	G;C;C	18;18;17	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1582	12.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	26	28	GTT	7;7;7	G;T;T	6;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1582	12.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	176	178	CAC	7;8;10	C;A;C	7;8;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1582	12.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	461	463	ATG	20;20;20	A;T;G	19;19;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1582	12.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1457	1459	CGC	9;9;10	C;G;C	9;9;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	129	96.9	arnA_1.l15.c4.ctg.2	129	6.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	10	12	GCT	2;2;2	G;C;T	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	164	96.34	arnA_1.l15.c4.ctg.5	164	7.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	8	10	TGC	3;3;3	T;G;C	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	456	arnA_1	1983	104	98.08	arnA_1.l15.c4.ctg.6	174	4.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	184	bacA	822	822	98.54	bacA.l15.c4.ctg.1	999	9.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	836	838	ACC	4;3;3	A;C;C	4;3;3	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	184	bacA	822	822	98.54	bacA.l15.c4.ctg.1	999	9.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	848	850	TCG	3;3;3	T;C;G	3;3;3	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	224	baeR	723	723	97.79	baeR.l6.c4.ctg.1	1077	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1525	12.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1234	1236	AAA	5;5;5	A;A;A	5;5;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1525	12.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1246	1248	GAG	4;3;2	G;A;G	4;2;2	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1525	12.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1252	1254	CAC	3;3;4	C;A;C	3;3;4	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1525	12.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1306	1308	GAG	13;14;14	G;A;G	13;14;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	490	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1473	16.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	302	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1030	15.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	240	cysB	975	975	99.38	cysB.l6.c30.ctg.1	1216	10.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	531	312	emrA	1173	1081	98.52	emrA.l6.c30.ctg.1	1088	13.6	0	.	p	.	0	W42C	NONSYN	124	126	TGG	126	128	TGT	3;3;3	T;G;T	3;3;3	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	531	312	emrA	1173	1081	98.52	emrA.l6.c30.ctg.1	1088	13.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	657	659	GTC	23;23;22	G;T;C	22;21;22	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	536	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	1911	14.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	350	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1540	12.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	784	786	AGC	10;11;11	A;G;C	10;10;11	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	16	emrE_1	333	91	96.7	emrE_1.l15.c4.ctg.1	91	4.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	228	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1116	9.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	583	585	AGG	6;6;6	A;G;G	6;6;6	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	228	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1116	9.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	973	975	GAC	9;8;7	G;A;C	9;8;7	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	192	emrR	531	531	100.0	emrR.l15.c30.ctg.1	836	12.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	364	emrY	1539	1539	99.81	emrY.l6.c4.ctg.1	1747	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	194	evgA	615	615	99.19	evgA.l6.c30.ctg.1	936	11.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	342	344	CTG	14;14;14	C;T;G	14;14;14	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	170	98.82	evgS.l15.c30.ctg.1	170	4.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	147	149	ACG	4;4;4	A;C;G	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	290	95.17	evgS.l15.c30.ctg.2	290	6.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	11	13	GAA	3;3;3	G;A;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	290	95.17	evgS.l15.c30.ctg.2	290	6.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	50	52	GCT	9;9;9	G;C;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	290	95.17	evgS.l15.c30.ctg.2	290	6.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	68	70	GAT	9;9;9	G;A;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	290	95.17	evgS.l15.c30.ctg.2	290	6.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	155	157	TCA	3;3;3	T;C;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	290	95.17	evgS.l15.c30.ctg.2	290	6.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	284	286	CAG	3;1;1	C;A;G	3;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	1175	99.06	evgS.l15.c30.ctg.3	1332	12.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	12	14	ATT	4;4;4	A;T;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	1175	99.06	evgS.l15.c30.ctg.3	1332	12.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	33	35	GAT	8;8;9	G;A;T	8;8;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	1175	99.06	evgS.l15.c30.ctg.3	1332	12.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	147	149	GTT	8;8;8	G;T;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	1175	99.06	evgS.l15.c30.ctg.3	1332	12.2	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	432	434	CAC	16;16;17	C;A;C	16;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	901	96.56	evgS.l15.c30.ctg.4	903	9.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	665	667	CAT	13;12;12	C;A;T	13;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	901	96.56	evgS.l15.c30.ctg.4	903	9.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	719	721	CAT	6;7;7	C;A;T	6;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	901	96.56	evgS.l15.c30.ctg.4	903	9.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	737	739	AGA	4;4;4	A;G;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	901	96.56	evgS.l15.c30.ctg.4	903	9.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	752	754	AAT	2;2;2	A;A;T	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	901	96.56	evgS.l15.c30.ctg.4	903	9.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	899	901	TCC	2;2;2	T;C;C	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	120	99.17	evgS.l15.c30.ctg.5	163	6.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	155	157	ATA	3;3;3	A;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	218	96.79	evgS.l15.c30.ctg.6	222	5.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	6;6;7	A;A;A	6;6;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	152	96.05	evgS.l15.c30.ctg.7	158	7.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	142	144	AAT	4;4;4	A;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	150	99.33	evgS.l15.c30.ctg.8	150	7.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	7	9	TCC	4;4;4	T;C;C	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	213	96.71	evgS.l15.c30.ctg.9	213	6.8	0	.	p	.	0	I251V	NONSYN	751	753	ATT	20	22	GTT	3;3;3	G;T;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	646	evgS	3594	213	96.71	evgS.l15.c30.ctg.9	213	6.8	0	.	p	.	0	N303D	NONSYN	907	909	AAT	176	178	GAT	1;1;1	G;A;T	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	294	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1194	13.2	1	SNP	p	P64L	0	.	.	190	192	CCA	359	361	CCA	19;18;17	C;C;A	19;18;17	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	294	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1194	13.2	1	SNP	p	P64A	0	.	.	190	192	CCA	359	361	CCA	19;18;17	C;C;A	19;18;17	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	294	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1194	13.2	1	SNP	p	P64H	0	.	.	190	192	CCA	359	361	CCA	19;18;17	C;C;A	19;18;17	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	294	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1194	13.2	1	SNP	p	P64R	0	.	.	190	192	CCA	359	361	CCA	19;18;17	C;C;A	19;18;17	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	294	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1194	13.2	1	SNP	p	P64S	0	.	.	190	192	CCA	359	361	CCA	19;18;17	C;C;A	19;18;17	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	132	gadE	528	528	100.0	gadE.l15.c30.ctg.1	853	8.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	40	gadW	729	127	93.7	gadW.l6.c30.ctg.1	177	2.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	147	149	ATG	1;1;1	A;T;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	40	gadW	729	127	93.7	gadW.l6.c30.ctg.1	177	2.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	150	152	CCG	1;1;1	C;C;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	180	gadX	825	825	97.94	gadX.l15.c30.ctg.1	913	10.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	160	162	TTA	8;8;8	T;T;A	8;8;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	180	gadX	825	825	97.94	gadX.l15.c30.ctg.1	913	10.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	238	240	ATT	7;7;7	A;T;T	7;7;7	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	180	gadX	825	825	97.94	gadX.l15.c30.ctg.1	913	10.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	739	741	GGA	12;13;13	G;G;A	12;13;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	180	gadX	825	825	97.94	gadX.l15.c30.ctg.1	913	10.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	745	747	CCG	11;12;12	C;C;G	11;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2108	2110	GAA	16;18;18	G;A;A	15;18;18	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	S83I	0	.	.	247	249	TCG	323	325	TCG	13;13;15	T;C;G	12;13;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	S83L	0	.	.	247	249	TCG	323	325	TCG	13;13;15	T;C;G	12;13;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	S83W	0	.	.	247	249	TCG	323	325	TCG	13;13;15	T;C;G	12;13;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	D87V	0	.	.	259	261	GAC	335	337	GAC	17;16;16	G;A;C	15;15;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	D87N	0	.	.	259	261	GAC	335	337	GAC	17;16;16	G;A;C	15;15;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	D87G	0	.	.	259	261	GAC	335	337	GAC	17;16;16	G;A;C	15;15;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	D87H	0	.	.	259	261	GAC	335	337	GAC	17;16;16	G;A;C	15;15;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	834	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2778	15.7	1	SNP	p	D87Y	0	.	.	259	261	GAC	335	337	GAC	17;16;16	G;A;C	15;15;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136G	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136L	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136C	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136I	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136H	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136E	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	872	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2718	17.2	1	SNP	p	R136S	0	.	.	406	408	CGC	584	586	CGC	11;11;12	C;G;C	11;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	176	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	888	10.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	358	360	CCG	10;10;10	C;C;G	10;10;10	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	176	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	888	10.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	511	513	GCC	12;12;12	G;C;C	12;12;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	382	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1192	16.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	67	69	TCA	12;12;13	T;C;A	12;12;13	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	150	marA	384	384	99.74	marA.l6.c4.ctg.1	764	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	483	485	AGC	6;5;5	A;G;C	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	V45E	0	.	.	133	135	GTG	309	311	GTG	7;7;7	G;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	I49S	0	.	.	145	147	ATC	321	323	ATC	10;10;10	A;T;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	A70T	0	.	.	208	210	GCA	384	386	GCA	7;7;7	G;C;A	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R73C	0	.	.	217	219	CGT	393	395	CGT	6;6;6	C;G;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R73S	0	.	.	217	219	CGT	393	395	CGT	6;6;6	C;G;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R77L	0	.	.	229	231	CGC	405	407	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R77C	0	.	.	229	231	CGC	405	407	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	L78M	0	.	.	232	234	CTG	408	410	CTG	3;3;3	C;T;G	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R94S	0	.	.	280	282	CGC	456	458	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	R94H	0	.	.	280	282	CGC	456	458	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	60	marR	435	385	97.92	marR.l6.c30.ctg.1	561	5.1	1	SNP	p	V96E	0	.	.	286	288	GTA	462	464	GTA	6;6;6	G;T;A	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	63	65	ATC	8;7;7	A;T;C	8;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	81	83	GCC	2;2;2	G;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	84	86	GTG	2;2;2	G;T;G	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	111	113	GAT	2;2;2	G;A;T	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	132	134	ACC	2;2;2	A;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	159	161	TTA	8;8;7	T;T;A	8;8;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	254	mdfA	1233	1190	95.82	mdfA.l6.c4.ctg.1	1313	10.0	0	.	p	.	0	G88fs	FSHIFT	262	262	G	219	219	G	8	G	8	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	677	98.38	mdtA.l15.c4.ctg.1	777	11.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	406	97.29	mdtA.l15.c4.ctg.2	407	8.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	83	85	ATC	8;8;8	A;T;C	8;8;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	406	97.29	mdtA.l15.c4.ctg.2	407	8.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	131	133	ATG	7;7;7	A;T;G	7;7;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	406	97.29	mdtA.l15.c4.ctg.2	407	8.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	224	226	ACC	7;7;7	A;C;C	7;7;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	156	94.23	mdtA.l15.c4.ctg.4	184	5.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	68	68	G	6	G	6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	156	94.23	mdtA.l15.c4.ctg.4	184	5.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	125	127	CAG	7;6;6	C;A;G	7;6;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1925	1927	ACC	19;19;19	A;C;C	19;19;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2318	2320	CAA	11;10;10	C;A;A	11;10;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2486	2488	ATT	6;6;6	A;T;T	6;6;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2570	2572	GTT	17;17;17	G;T;T	17;16;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2678	2680	GAG	11;11;10	G;A;G	11;11;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2906	2908	ATG	7;7;7	A;T;G	7;7;7	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	918	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3377	14.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3041	3043	GAT	15;15;15	G;A;T	15;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	772	mdtC	3078	2922	98.77	mdtC.l6.c4.ctg.1	3073	13.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	287	289	ATG	7;7;7	A;T;G	6;7;6	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	772	mdtC	3078	2922	98.77	mdtC.l6.c4.ctg.1	3073	13.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	773	775	ATC	14;16;17	A;T;C	14;16;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	772	mdtC	3078	102	98.04	mdtC.l6.c4.ctg.2	123	6.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	310	mdtD	1416	1071	98.23	mdtD.l6.c30.ctg.1	1238	10.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	331	333	GCG	14;14;14	G;C;G	14;14;14	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	310	mdtD	1416	1071	98.23	mdtD.l6.c30.ctg.1	1238	10.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	673	675	ATC	11;11;11	A;T;C	11;11;11	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	310	mdtD	1416	1071	98.23	mdtD.l6.c30.ctg.1	1238	10.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	976	978	TTT	11;11;12	T;T;T	11;11;12	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	310	mdtD	1416	325	99.08	mdtD.l6.c30.ctg.2	437	6.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	119	121	GAA	5;5;5	G;A;A	5;5;5	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	498	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1296	19.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1050	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3500	16.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1066	1068	ACC	17;16;16	A;C,A;C	17;13,1;16	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1050	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3500	16.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2308	2310	GAC	27;27;27	G;A;C	24;26;25	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	388	mdtG	1227	1011	99.41	mdtG.l15.c4.ctg.1	1220	13.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	382	384	ATC	10;10;9	A;T;C	10;10;9	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	388	mdtG	1227	174	99.43	mdtG.l15.c4.ctg.4	232	7.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	5	7	GGA	2;2;2	G;G;A	2;2;2	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	364	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1476	13.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	562	564	TGT	20;21;21	T;G;T	20;21;21	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	364	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1476	13.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1132	1134	TTG	11;12;12	T;T;G	11;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	364	mdtH	1209	1209	98.18	mdtH.l6.c4.ctg.1	1476	13.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1342	1344	ACG	5;5;5	A;C;G	5;5;5	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	408	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1549	14.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	742	744	TCC	10;10;11	T;C;C	10;10;11	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	300	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1378	11.1	0	.	p	.	0	V119I	NONSYN	355	357	GTT	403	405	ATT	4;5;6	A;T;T	4;5;6	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	965	97.82	mdtO.l15.c17.ctg.1	1137	13.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	203	205	ATG	9;9;11	A;T;G	9;9;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	965	97.82	mdtO.l15.c17.ctg.1	1137	13.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	269	271	ATC	14;14;15	A;T;C	14;14;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	965	97.82	mdtO.l15.c17.ctg.1	1137	13.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	518	520	CGC	28;27;26	C;G;C	28;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	965	97.82	mdtO.l15.c17.ctg.1	1137	13.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	884	886	AGC	4;4;5	A;G;C	4;4;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	965	97.82	mdtO.l15.c17.ctg.1	1137	13.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1085	1087	GTG	10;11;12	G;T;G	10;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	1064	98.5	mdtO.l15.c17.ctg.2	1242	18.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	33	35	GTC	10;12;13	G;T;C	10;12;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	1064	98.5	mdtO.l15.c17.ctg.2	1242	18.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	63	65	ATA	21;21;21	A;T;A	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	1064	98.5	mdtO.l15.c17.ctg.2	1242	18.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	171	173	TCT	11;12;12	T;C;T	11;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	1064	98.5	mdtO.l15.c17.ctg.2	1242	18.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	558	560	GCG	14;13;13	G;C;G	14;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	714	mdtO	2052	1064	98.5	mdtO.l15.c17.ctg.2	1242	18.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	771	773	ATC	15;15;15	A;T;C	15;15;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	385	385	T	14	T	13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	568	570	GCG	6;6;7	G;C;G	6;6;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	742	744	ACC	11;11;11	A;C;C	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	814	816	CGC	17;16;14	C;G;C	17;16;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	931	933	GCT	19;18;18	G;C;T	19;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1015	1017	AAA	7;7;7	A;A;A	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1033	1035	CGA	8;7;7	C;G;A	8;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1198	1200	GCC	11;11;11	G;C;C	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	392	mdtP	1467	1442	97.99	mdtP.l15.c4.ctg.1	1631	12.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1210	1212	GAT	11;11;11	G;A;T	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1054	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3852	14.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1523	1525	AAG	15;15;16	A;A;G	15;14;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1054	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3852	14.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2600	2602	CTG	10;10;10	C;T;G	10;10;10	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	54	mgrB	144	144	100.0	mgrB.l15.c4.ctg.3	163	8.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	684	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	1981	18.2	0	.	p	.	0	S278N	NONSYN	832	834	AGC	990	992	AAC	9;8;8	A;A;C	9;8;8	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	684	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	1981	18.2	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1536	1538	ATA	19;19;18	A;T;A	19;19;17	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	482	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1637	15.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1283	1285	GAT	22;22;21	G;A;T	22;22;21	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	482	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1637	15.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1286	1288	CTG	20;19;19	C;T;G	20;19;19	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	260	262	TGT	10;10;9	T;G;T	10;10;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	530	532	ACC	14;14;14	A;C;C	13;14;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	740	742	GAC	19;19;19	G,T;A;C	18,1;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	1	SNP	p	R15C	0	.	.	43	45	CGC	224	226	CGC	26;25;25	C;G;C	26;25;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	1	SNP	p	S33R	0	.	.	97	99	AGC	278	280	AGC	8;7;7	A;G;C	8;7;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	1	SNP	p	G131D	0	.	.	391	393	GGC	572	574	GGC	19;19;19	G;G;C	19;19;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	1	SNP	p	R203L	0	.	.	607	609	CGT	788	790	CGT	7;7;7	C;G;T	7;7;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	212	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1041	10.7	1	SNP	p	R203C	0	.	.	607	609	CGT	788	790	CGT	7;7;7	C;G;T	7;7;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1442	15.9	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1104	1106	GAG	16;15;15	G;A;G	16;15;15	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1442	15.9	1	SNP	p	G141E	0	.	.	421	423	GGT	591	593	GGT	28;28;29	G;G;T	28;28;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1442	15.9	1	SNP	p	G141D	0	.	.	421	423	GGT	591	593	GGT	28;28;29	G;G;T	28;28;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1442	15.9	1	SNP	p	R154D	0	.	.	460	462	CGT	630	632	CGT	27;26;25	C;G;T	27;26;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1442	15.9	1	SNP	p	R154A	0	.	.	460	462	CGT	630	632	CGT	27;26;25	C;G;T	27;26;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2638	17.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1809	1811	TCG	30;30;30	T;C;G	28;28;29	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2638	17.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2424	2426	AAC	11;11;11	A;A;C	11;11;11	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2638	17.1	1	SNP	p	A85T	0	.	.	253	255	GCG	438	440	GCG	22;21;20	G;C;G	22;21;20	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2638	17.1	1	SNP	p	D111H	0	.	.	331	333	GAT	516	518	GAT	21;21;21	G;A;T	21;21;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2638	17.1	1	SNP	p	S129P	0	.	.	385	387	TCC	570	572	TCC	27;28;28	T;C;C	27;28;28	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	498	parE_1	1893	927	98.17	parE_1.l6.c4.ctg.1	1114	12.2	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	465	467	GCT	16;17;17	G;C;T	16;17;17	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	498	parE_1	1893	604	96.85	parE_1.l6.c4.ctg.2	604	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	498	parE_1	1893	162	98.15	parE_1.l6.c4.ctg.3	343	7.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	498	parE_1	1893	237	96.62	parE_1.l6.c4.ctg.4	240	12.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	498	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1768	15.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1277	1279	GAT	13;14;14	G;A;T	13;14;14	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	V146F	0	.	.	436	438	GTT	619	621	GTT	28;28;27	G;T;T	28;28;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1720	1722	CAG	18;18;18	C;A;G	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1720	1722	CAG	18;18;18	C;A;G	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1759	1761	CAC	20;22;22	C;A;C	20;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1768	1770	CGT	18;19;19	C;G;T	18;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1768	1770	CGT	18;19;19	C;G;T	18;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1774	1776	TCC	19;19;18	T;C;C	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1780	1782	CTC	18;18;18	C;T;C	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1870	1872	ACC	20;21;21	A;C;C	20;20;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1873	1875	CCT	20;21;21	C;C;T	19;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1738	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4274	21.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2242	2244	CGT	29;27;27	C;G;T	28;27;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	139	100.0	rrsB+.l15.c30.ctg.1	139	22.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	.	n	.	0	A226G	SNP	226	226	A	371	371	G	119	G,A	116,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	1	SNP	n	A794G	0	.	.	794	794	A	939	939	A	129	A	123	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	1	SNP	n	A794T	0	.	.	794	794	A	939	939	A	129	A	123	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	1	SNP	n	G926A	0	.	.	926	926	G	1071	1071	G	127	G	127	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	1	SNP	n	G926C	0	.	.	926	926	G	1071	1071	G	127	G	127	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	1	SNP	n	G926T	0	.	.	926	926	G	1071	1071	G	127	G	127	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	T273A	.	273	273	T	418	418	T	113	T,A	87,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	C183T	.	183	183	C	328	328	C	121	C,T	87,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	T90C	.	90	90	T	235	235	T	119	T,C	93,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	A250T	.	250	250	A	395	395	A	131	A,T	91,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	G474A	.	474	474	G	619	619	G	121	G,A	98,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	A253T	.	253	253	A	398	398	A	130	A,T	90,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	C194T	.	194	194	C	339	339	C	111	C,T	90,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	C719T	.	719	719	C	864	864	C	107	C,T	58,48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1145	110.9	0	HET	.	.	.	A79G	.	79	79	A	224	224	A	119	A,G	92,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.4	516	139.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	479	479	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.4	516	139.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	479	479	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.4	516	139.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	479	479	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	G1002A	SNP	1002	1002	G	52	52	A	45	A	45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	G1006C	SNP	1006	1006	G	56	56	C	46	C	46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	T1010C	SNP	1010	1010	T	60	60	C	48	C	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	A1019.	DEL	1019	1019	A	68	68	G	48	G	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	.1023G	INS	1023	1023	T	73	73	G	51	G	50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4098	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.6	138	23.8	0	.	n	.	0	C1038T	SNP	1038	1038	C	88	88	T	37	T	37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	182	soxR	465	465	100.0	soxR.l15.c4.ctg.1	698	13.7	1	SNP	p	R20H	0	.	.	58	60	CGC	215	217	CGC	17;15;16	C;G;C	16;15;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	182	soxR	465	465	100.0	soxR.l15.c4.ctg.1	698	13.7	1	SNP	p	G121D	0	.	.	361	363	GGT	518	520	GGT	16;16;16	G;G;T	16;16;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	158	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	700	12.0	1	SNP	p	A12S	0	.	.	34	36	GCA	236	238	GCA	14;14;16	G;C;A	14;14;16	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	582	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1843	17.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
